Inhibition of autoimmune encephalomyelitis by a tetracycline

Annals of Neurology

Volumn 51, Issue 2, 2002, Pages 215-223

  Popovic, Natalija ^a   Schubart, Anna ^b   Goetz, Brian D ^b   Zhang, Su Chun ^a   Linington, Chris ^b   Duncan, D ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; METALLOPROTEINASE; METALLOPROTEINASE 2; MINOCYCLINE; NEUROPROTECTIVE AGENT; TETRACYCLINE DERIVATIVE; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEMYELINATING DISEASE; DRUG EFFICACY; EXPERIMENTAL MODEL; FEMALE; INFLAMMATORY DISEASE; MICROGLIA; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; RECURRENT DISEASE; RELAPSE;

ANIMALS; ANTI-BACTERIAL AGENTS; BRAIN; CHRONIC DISEASE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; IMMUNIZATION; MINOCYCLINE; MYELIN-ASSOCIATED GLYCOPROTEIN; RATS; RECURRENCE; TH1 CELLS; TH2 CELLS;

EID: 0036157268     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10092     Document Type: Article

References (35)

1. Progress in determining the causes and treatment of multiple sclerosis
2. Axonal transection in the lesions of multiple sclerosis
3. Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability
4. Multiple sclerosis and chronic autoimmune encephalomyelitisa comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions
5. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia
6. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window
7. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia
8. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease
9. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology
10. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: A case for antigen-specific antibody mediation
11. Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomy elitis in the "resistant" brown Norway rat: Disease susceptibility is determined by MHC and MHC-linked effects on the B cell response
12. DNA vaccination induced autoaggression: Exacerbation of experimental autoimmune encephalitis (EAE) following DNA vaccination with myelin oligodendrocyte glycoprotein
13. Minocycline for the treatment of rheumatoid arthritis
14. Treatment of destructive arthritic disorders with MMP inhibitors. Potential role of tetracyclines
15. + T cells in the pathogenesis of organ-specific autoimmune diseases
16. Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Th1 cells
17. Interleukin-12 induces interferon γdependent switching of IgG alloantibody subclass
18. Interleukin-10 is an unequivocal Th2 parameter in the rat, whereas interleukin-4 is not
19. Interleukin-10 prevents experimental allergic encephalomyelitis in rats
20. The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement
21. Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors
22. Matrix metalloproteinases in inflammatory demyelination
23. Distinct roles for matrix metalloproteinase-2 and α4 integrin in autoimmune T cell extravasation and residency in brain parenchyma during experimental autoimmune encephalomyelitis
24. Matrix metalloproteinases and diseases of the CNS
25. Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage
26. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis
27. Microglia as mediators of inflammatory and degenerative diseases
28. Indictment of the microglia as the villain in multiple sclerosis
29. Minocycline provides neuroprotection against n-methyl-D-aspartate neurotoxicity by inhibiting microglia
30. Glutamate excitotoxicity in a model of multiple sclerosis
31. Autoimmune encephalomyelitis ameliorated by AMPA antagonists
32. The link between excitotoxic oligodendroglial death and demyelinating diseases
33. Safety of long-term high dose minocycline in the treatment of acne
34. Peroxisomal disorders: Genotype, phenotype, major neuropathologic lesions and pathogenesis
35. Macrophage responses in inflammatory demyelinating neuropathies